Trial · NCT00003473
Adverse events101
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 101
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Allergic reaction/hypersensitivity (including drug fever) | Immune system disorders | Antineoplaston Therapy | 4 | 20 | |
| other | Allergy/Immunology - Other | Immune system disorders | Antineoplaston Therapy | 1 | 20 | |
| other | Auditory/Ear - Other | Ear and labyrinth disorders | Antineoplaston Therapy | 1 | 20 | |
| other | Hearing (without monitoring program) | Ear and labyrinth disorders | Antineoplaston Therapy | 2 | 20 | |
| other | Tinnitus | Ear and labyrinth disorders | Antineoplaston Therapy | 1 | 20 | |
| other | Hemoglobin | Blood and lymphatic system disorders | Antineoplaston Therapy | 5 | 20 | |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | Antineoplaston Therapy | 4 | 20 | |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | Antineoplaston Therapy | 2 | 20 | |
| other | Platelets | Blood and lymphatic system disorders | Antineoplaston Therapy | 4 | 20 | |
| other | Palpitations | Cardiac disorders | Antineoplaston Therapy | 1 | 20 | |
| other | Hypertension | Cardiac disorders | Antineoplaston Therapy | 2 | 20 | |
| other | Central Venous Catheter Infection | Infections and infestations | Antineoplaston Therapy | 1 | 20 | |
| other | Central Venous Catheter Non-functional | General disorders | Antineoplaston Therapy | 6 | 20 | |
| other | Central Venous Catheter Thrombosis/embolism | General disorders | Antineoplaston Therapy | 1 | 20 | |
| other | INR (International Normalized Ratio of prothrombin time) | Blood and lymphatic system disorders | Antineoplaston Therapy | 1 | 20 | |
| other | Fatigue (asthenia, lethargy, malaise) | General disorders | Antineoplaston Therapy | 13 | 20 | |
| other | Fever | General disorders | Antineoplaston Therapy | 5 | 20 | |
| other | Insomnia | General disorders | Antineoplaston Therapy | 1 | 20 | |
| other | Rigors/chills | General disorders | Antineoplaston Therapy | 3 | 20 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Antineoplaston Therapy | 1 | 20 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00003473/events